Article
Human papillomavirus genotype specificity of hybrid capture 2.
Journal of clinical microbiology - 1 Aug 2008
Castle Philip E, Solomon Diane, Wheeler Cosette M, Gravitt Patti E, Wacholder Sholom, Schiffman Mark
Abstract excerpt
Hybrid Capture 2 (hc2), a clinical test for carcinogenic human papillomavirus (HPV) DNA, has proven to be a sensitive but only modestly specific predictor of cervical precancer and cancer risk. Some of its nonspecificity for clinical end points can be ascribed to cross-reactivity with noncarcinogenic HPV genotypes. However, the reference genotyping tests that have been used for these comparisons are also...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
